Welcome to ASENT

The American Society for Experimental NeuroTherapeutics (ASENT) is an independent non-profit organization established in 1997 by leaders in academia, government, advocacy and industry to facilitate the process by which new therapies are made available to patients with neurological disorders.

Our primary goal is to encourage and advance the development of improved therapies for diseases and disorders of the nervous system.  Read the President's Message

19th Annual Meeting Highlights

Thank you for attending the 19th Annual American Society of Neurotherapeutics (ASENT) Meeting at the Hilton Washington DC/Rockville Hotel and Executive Meeting Center in Rockville, Maryland.

The Pipeline Session is unique to ASENT. Twenty-five (25) presentations were heard about the discovery and development of new CNS therapy candidates.  Sessions addressed Alzheimer’s disease, big data, neuromodulation, drug repurposing, regulatory processes for dose determination and prescribing, rapidly-acting antidepressants, pharmacogenetics, the placebo eff ect, and a special session on Parkinson’s disease honoring Stan Fahn, MD, Columbia University, an ASENT founder.

   

ASENT Commemorative Founders Award 
Presented for contributions to ASENT and in advancing the science of Neurotherapeutics

Stanley Fahn, MD, is the H. Houston Merritt Professor of Neurology and Director of the Center for Parkinson’s Disease and Other Movement Disorders at Columbia University in New York City. He is the Scientific Director of the Parkinson’s Disease Foundation and served as President of the American Academy of Neurology (AAN) from 2001 to 2003. He works on clinical and experimental therapeutics of movement disorders, including Parkinson disease (PD).

Read more.....

In Memory of Jeffrey Nye, M.D., Ph.D

It is with a heavy heart that we announce the passing of Jeffrey Nye M.D., Ph.D. Jeff was a tremendously enthusiastic and committed member of the ASENT leadership.

His passing is a loss not only to ASENT, but to the entire community of those working to bring neurological therapies to patients in need. In his honor, the ASENT Leadership Fund to support annual meeting scholarships to basic and clinical neuroscientists will be renamed the Jeffrey Nye M.D., Ph.D. Leadership Fund.

Read more....

Clinical Translation Course

The Clinical Translation Course is a new, novel economic approach to this most difficult area. Some of the topics include: Introduction to the Health-Tech Innovation Cycle, Identifying the Economic Buyer in a Healthcare Ecosystem, Defining Clinical Needs and the Value Proposition, Creating a Sustainable Business Model, and Intellectual Property Funding and the SBIR/STTR Program.  

View 2016 Course Agenda

Calendar more

11/11/2017 » 11/15/2017
Society for Neuroscience

3/13/2018 » 3/18/2018
2018 Annual Meeting

 

Benefits of Membership include:

  • Subscription to Neurotherapeutics the journal, a quarterly publication focused on critical reviews of topics essential to current and future central nervous system therapeutics ($99 value);
  • Discounted registration fee for the ASENT annual meeting (up to a $150 value);
  • A scientific forum for publication and abstract presentations through the Annual Meeting and journal;
  • Access to the password-protected members' only directory on the website, to allow networking with your colleagues.
   
    Jeffrey S. Nye Leadership Fund provides support to attend the ASENT Annual Meeting to trainees in fields related to neurotherapeutics. These attendees will be the future members, and ultimately leaders, of our society.  Donate Today!
 

A 3½-day short course to introduce academic researchers to the principles of neurotherapeutic drug discovery and development

 

 


ASENT Supporters